Filing Details

Accession Number:
0000896262-21-000074
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-02 16:15:55
Reporting Period:
2021-05-28
Accepted Time:
2021-06-02 16:15:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896262 Amedisys Inc AMED Services-Home Health Care Services (8082) 113131700
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1543701 G Scott Ginn 3854 American Way, Suite A
Baton Rouge LA 70816
Evp & Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-05-28 975 $27.35 30,084 No 4 M Direct
Common Stock Disposition 2021-05-28 975 $261.60 29,109 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-05-28 975 $0.00 975 $27.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-05-01 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,714 Indirect Through 401(k) Plan
Footnotes
  1. The total amount of shares beneficially owned includes 887 shares held in an employee stock purchase plan account.
  2. These sales were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  3. The information in this report is based on a plan statement dated as of March 31, 2021.
  4. On May 1, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2015, 2016, 2017 and 2018. The performance criteria for 2018 were met, resulting in vesting of the option as to 5,625 shares (the "2018 Tranche Options"), subject to additional time-based vesting as follows: one-third of the 2018 Tranche Options vested on May 1, 2019 and two-thirds of the 2018 Tranche Options vested on May 1, 2020. After the transactions reported in this Form 4, all of the 2018 Tranche Options have been exercised.